Condition: Age-Related Macular Degeneration · Geographic Atrophy · Sponsor: VisionCare, Inc.
The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
This description comes directly from the study's public registry record.
Rebecca Kammer, OD, PhD · +1 (714) 728-1575 · rkammer@samsaravision.com
Colleen Collier · +1 (609) 213-9420 · ccollier@samsaravision.com
Always discuss trial participation with your own doctor first.
| Loma Linda University | Loma Linda, California, United States | Recruiting |
| Eye Physicians of Long Beach | Long Beach, California, United States | Recruiting |
| Sarasota Retina Institute | Sarasota, Florida, United States | Recruiting |
| Tallman Eye Associates | Lawrence, Massachusetts, United States | Recruiting |
| Oakland Ophthalmic Surgery | Birmingham, Michigan, United States | Recruiting |
| Vance Thompson Vision | Omaha, Nebraska, United States | Recruiting |
| Atlantic Eye Physicians | Eatontown, New Jersey, United States | Recruiting |
| Western Carolina Retinal Associates | Asheville, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cole Eye Institute | Cleveland, Ohio, United States | Recruiting |
| Methodist Eye Associates | Houston Methodist | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05438732